You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nab-paclitaxel

Showing 51 - 75 of 338
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Cancer Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Metastatic Pancreatic Cancer
  • Nab-paclitaxel
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

Completed
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +6 more
  • Houston, Texas
  • +4 more
Aug 31, 2022

Resectable Biliary Tract Cancer Trial in Tianjin (Cisplatin, Gemcitabine, Nab-paclitaxel)

Recruiting
  • Resectable Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Nov 30, 2022

Metastatic Pancreatic Cancer Trial in Spain (OMO-103, Nab-Paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Cancer
  • L´Hospitalet de Llobregat, Barcelona, Spain
  • +3 more
Sep 22, 2023

Cancer Trial in United States (Gemcitabine, Nab-paclitaxel)

Recruiting
  • Cancer
  • Aurora, Colorado
  • +3 more
Oct 28, 2021

Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma Trial in Duarte

Recruiting
  • Stage III Pancreatic Cancer AJCC v8
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2021

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

Withdrawn
  • Triple Negative Breast Cancer
  • +4 more
  • Nab-paclitaxel
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 2, 2022

Breast Cancer Trial in United States (Mifepristone, Placebo, Nab-Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +4 more
Mar 14, 2022

High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab-paclitaxel)

Recruiting
  • High-Risk
  • Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Oct 22, 2021

Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

Not yet recruiting
  • Stage II-IIIB(N2) Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 26, 2023

Solid Tumor Trial (IN10018, Nab-paclitaxel, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Aug 1, 2023

Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

Recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Mar 28, 2023

STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER Trial in United States (NAB-PACLITAXEL, PACLITAXEL)

Completed
Has Results
  • STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
  • Rochester, New York
  • +4 more
Oct 5, 2021

Metastatic Pancreatic Adenocarcinoma Trial in Madrid (nab-paclitaxel, gemcitabine, m-FOLFOX)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • nab-paclitaxel
  • +2 more
  • Madrid, Spain
    Spanish Cooperative for Digestive Tumour Therapy (TTD)
Aug 11, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Orange, California
  • +15 more
Aug 23, 2022

Nab-Paclitaxel in Combination With Carboplatin as First-line

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Freiburg, Baden-Württemberg, Germany
    iOMEDICO
Oct 5, 2021

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Woodville South, Melbourne, Subiaco (CEND-1, Nab-paclitaxel,

Completed
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Woodville South, South Australia, Australia
  • +2 more
Oct 26, 2022

Triple Negative Breast Cancer Trial in Guangzhou (SG001, Nab-paclitaxel)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Oct 13, 2021

Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma Trial in Germany (Romidepsin, Azacitidine,

Recruiting
  • Pancreas Cancer
  • +2 more
  • Essen, Germany
  • +8 more
May 17, 2022

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Non Small Cell Lung Cancer, Advanced Lung Non-Small Cell Carcinoma, PD-L1 Gene Mutation Trial (Pembrolizumab, Pemetrexed,

Withdrawn
  • Non Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Mar 14, 2022

Triple-Negative Breast Cancer Trial in China (JS001, Nab-Paclitaxel, Placebo)

Recruiting
  • Triple-Negative Breast Cancer
  • Beijing, Beijing, China
  • +55 more
Sep 13, 2022

Adenocarcinoma Pancreas Trial in Mannheim (Nab-paclitaxel, Gemcitabine, Best Supportive Care)

Completed
  • Adenocarcinoma Pancreas
  • Nab-paclitaxel
  • +2 more
  • Mannheim, Germany
    Universitätsklinikum Mannheim II. Medizinische Klinik
Aug 3, 2021

Metastatic Head-and-neck Squamous-cell Carcinoma Trial in Saint Louis (nab-paclitaxel, Nivolumab)

Recruiting
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 29, 2021